Oral versus IV treatment for catheter-related bloodstream infections [5]

Emerging Infectious Diseases

Volumn 13, Issue 11, 2007, Pages 1800-1801

  Cunha, Burke A ^a,b  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

CATHETER INFECTION; CLINICAL ASSESSMENT; CLINICAL FEATURE; DRUG EFFECT; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LETTER; TREATMENT OUTCOME;

EID: 36248978686     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1311.070729     Document Type: Letter

References (5)

1. Halton K, Graves N. Economic evaluation and catheter-related bloodstream infections. Emerg Infect Dis. 2007;13:815-23.
2. Gastmeier P, Geffers C. Prevention of catheter-related bloodstream infections: analysis of studies published between 2002 and 2005. J Hosp Infect. 2006;64:326-35.
3. Cunha BA. Antibiotic essentials, 6th edition. Royal Oak (MI): Physicians Press; 2007. p 61-4.
4. Cunha BA. Oral antibiotic therapy of serious systemic infections. Med Clin North Am. 2006;90: 1197-222.
5. Cunha BA. Antimicrobial therapy of multidrug-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci, and methicillin-resistant Staphylococcus aureus. Med Clin North Am. 2006;90:1165-82.